On Thursday, Shares of Gilead Sciences, Inc. (NASDAQ:GILD), added 0.04% and closed at $73.06 in the last trading session. The last trading range of the stock ranges between $72.21 and $73.93. Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The companys products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, in addition to diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners.
FirstEnergy Corp. (NYSE:FE), jumped 0.64% and closed at $31.56 in the last trading session. The last trading range of the stock ranges between $31.26 and $31.83. The company’s Market capitalization is $13.48 Billion with the total outstanding Shares of 425.20 million. FirstEnergy Corp.’s (FE) Ohio utilities – Ohio Edison, Cleveland Electric Illuminating and Toledo Edison – recently declared that the Public Utilities Commission of Ohio (PUCO) has approved modifications to Powering Ohio’s Progress, the companies’ comprehensive Electric Security Plan (ESP) originally approved in March.
The PUCO order authorizes the companies to collect about $204 million per year over a three-year term. The charge is expected to result in a $3 increase on monthly bills, or about three percent, for a typical residential customer using 750 kilowatt-hours per month. With the new charge, total monthly bills for FirstEnergy’s residential customers are expected to be lower than they were a year ago and remain among the lowest in the state.
“Recently’s decision is disappointing for our customers,” said Charles E. Jones, FirstEnergy President and Chief Executive Officer. “While we clearly demonstrated to the PUCO what is essential to ensure reliability for customers in the future, the amount granted is insufficient to cover the necessary and costly investments. The decision also fails to recognize the noteworthychallenges that threaten Ohio utilities’ ability to effectively operate.”